Abstracts Archive - Page 972 of 2425 - ACR Meeting Abstracts

Abstract Number: 265 • 2019 ACR/ARP Annual Meeting
Frequency of Performing Anti dsDNA Antibody in an ANA Negative Patient with Clinical Suspicion of SLE in a Single Centre Trial Before and After the Publication of National Guideline
Pamela Anjara ¹, David Liew², Victor Yang ³, Christopher McMaster ² and Russell Buchanan ³, ¹Austin Hospital, Melbourne, Victoria, Australia, ²Austin Health, Melbourne, Victoria, Australia, ³Austin Health, Heidelberg, Victoria, Australia
Background/Purpose: In October 2017, the Australian Rheumatology Association widely promoted a list of five recommendations on low-value practices to general clinicians and patients as part…
Abstract Number: 266 • 2019 ACR/ARP Annual Meeting
Measuring Advanced/Extended Practice Roles in Arthritis and Musculoskeletal Care in Canada: Stand up and Be Counted Too (2)!
Katie Lundon¹, Taucha Inrig ², Morag Paton ¹, Rachel Shupak ², Carol Kennedy ², Mandy McGlynn ³ and Claire Barber ⁴, ¹University of Toronto, Toronto, ²St. Michael's Hospital, Toronto, ON, Canada, ³UHN, Toronto, ⁴University of Calgary, Calgary, Canada
Background/Purpose: Arthritis and musculoskeletal disorders are the most common chronic health conditions in Canada but there is a critical and growing shortage of rheumatologists relative…
Abstract Number: 267 • 2019 ACR/ARP Annual Meeting
Develop Risk Prediction Model and Drug Withdrawl Road Map Through Pattern Extraction and Data Mining: Create a Master Algorithm from the Smart System of Disease Management (SSDM)
Yan Zhao¹, Xiaomei Li ², Rong Mu ³, Xiaoxia Zuo ⁴, Hua Wei ⁵, Lingli Dong ⁶, Shouxin Li ⁶, Hongsheng Sun ⁷, Guanmin Gao ⁸, Lijun Wu ⁹, Bing Wu ¹⁰, Yuhua Jia ¹¹, Hui Xiao ¹², Minghua Xu ¹³, Wenyu Zhou ¹⁴, Aichun Chu ¹⁵, Li Dong ¹⁶, Huiqin Yang ¹⁷, Ming Gui ¹⁸, Weiqi Min ¹⁹, Zhenchun Zhang ²⁰, Ying Pan ²¹, Junli Zhang ²², Jinchang He ²³, Haiying Chen ²⁴ and Fei Xiao ²⁵, ¹Peking Union Medical College hospital, Beijing, Beijing, China (People's Republic), ²the First Affiliated Hospital of University of Science and Technology of China, Hefei, China (People's Republic), ³People's Hospital, Beijing University Medical School, Beijing, China (People's Republic), ⁴Xiangya Hospital Centeral South University, Changsha, China (People's Republic), ⁵Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), ⁶Tongji Hospital，Tongji Medical Colllege，Huazhong University of Science and Technology, Wuhan, Hubei, China (People's Republic), ⁷Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China (People's Republic), ⁸the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China (People's Republic), ⁹People's Hospital of Xinjiang Uygur Autonomous region, Wulumuqi, Xinjiang, China (People's Republic), ¹⁰Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ¹¹Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ¹²Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ¹³Affiliated Hospital of Hebei University, Baoding, China (People's Republic), ¹⁴WuHan Fourth Hospital, Wuhan, China (People's Republic), ¹⁵Hubei general hospital, Wuhan, China (People's Republic), ¹⁶Jingzhou Central Hospital, Jingzhou, China (People's Republic), ¹⁷Wuhan NO.1 Hospital, Wuhan, China (People's Republic), ¹⁸The third xiangya hospital of central south university, Changsha, China (People's Republic), ¹⁹Heze municipal hospital, Heze, China (People's Republic), ²⁰Linyi People's Hospital, Linyi, China (People's Republic), ²¹the First Affiliated Hospital of xi'an Jiaotong University, Xi'an, China (People's Republic), ²²Xi'an Fifth Hospital, Xian, China (People's Republic), ²³Panzhihua Central Hospital, Panzhihua, China (People's Republic), ²⁴The Third Hospital of Hebei Medical University, Shijiazhang, China (People's Republic), ²⁵Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)
Background/Purpose: Combination therapy with DMARDs for treating RA is considered as a standard of care. However, certain rates of adverse events (AEs) are unavoidable. The…
Abstract Number: 268 • 2019 ACR/ARP Annual Meeting
LARS Study: Latin American Rheumatologist Survey
Genessis Maldonado¹, Maria Intriago ¹, Enrique Soriano ², Letty Moreno ³ and Carlos Rios ¹, ¹Universidad Espiritu Santo, Guayaquil, Ecuador, ²Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina, ³Centro de Reumatología y Rehabilitación, Guayaquil, Ecuador
Background/Purpose: :Currently, Latin America does not have detailed information of rheumatologists in the region based on: education, working conditions, productivity, distribution of time between work…
Abstract Number: 269 • 2019 ACR/ARP Annual Meeting
Attitudes and Beliefs About Opioid Medications: Determining Treatment Use in Osteoarthritis
Ernest Vina¹, Jazmin Dagnino ¹ and C. Kent Kwoh ¹, ¹University of Arizona, Tucson, AZ
Background/Purpose: Considering the growing opioid epidemic in the US, it is imperative to have a good understanding of what patient characteristics predict the use of…
Abstract Number: 270 • 2019 ACR/ARP Annual Meeting
Outcomes of a Fracture Liaison Service at an Academic Health Center
Micah Yu¹, Donna Jose ², Parke Hudson ², Christina Downey, MD ³, Wesley Phipatanakul ², Silvana Giannelli ², Kevin Codorniz ⁴ and Karina Torralba ⁵, ¹Loma Linda University Medical Center, loma linda, ²Loma Linda University, Loma Linda, ³Loma Linda University Medical Center, Loma LInda, CA, ⁴[email protected], Loma Linda, ⁵Loma Linda University School of Medicine, Loma Linda, CA
Background/Purpose: Osteoporosis is associated with increased morbidity and mortality. There is a 60% risk of a subsequent fracture for patients who have had one fracture,…
Abstract Number: 271 • 2019 ACR/ARP Annual Meeting
Who Prescribed Which Osteoporosis Medication to Whom
Jiannong Liu¹, Haifebg Guo ¹, Tingting Gong ¹ and Yi Peng ², ¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN
Background/Purpose: Several osteoporosis (OP) medicines came on the market in the past two decades, each with its own indications. However, there is no clear information…
Abstract Number: 272 • 2019 ACR/ARP Annual Meeting
Osteoporosis Management Outcomes in a Southern California County Health System
Lorien Ahn¹, Jordan Thompson ¹, Nancy Collado ², Micah Yu ², Anna Lafian ², Christina Downey, MD ³ and Karina Torralba ⁴, ¹Loma Linda University, Loma linda, ²Loma Linda University Medical Center, loma linda, ³Loma Linda University Medical Center, Loma LInda, CA, ⁴Loma Linda University School of Medicine, Loma Linda, CA
Background/Purpose: Fragility fractures (FF) are a sentinel event in osteoporosis and world-wide only 20% of patients with a FF receive treatment, a large care gap.…
Abstract Number: 273 • 2019 ACR/ARP Annual Meeting
Bone Health in Lupus: Findings from the Southern California Lupus Registry
Vaneet Sandhu, MBBS¹ and Sara Johnson ², ¹Loma Linda University, Loma Linda, CA, ²St George's University, Loma Linda, CA
Background/Purpose: The association of vitamin D deficiency with SLE is well established. While disease activity can itself cause pathologic bone remodeling and reduced vitamin D,…
Abstract Number: 274 • 2019 ACR/ARP Annual Meeting
Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis
Dina Jones¹, Louise Murphy ², Ranjita Misra ¹, Alison Vargovich ³, Dana Guglielmo ⁴, Maura Robinson ¹, Samantha Shawley-Brzoska ¹, Sijin Wen ¹, Megan Burkart ¹ and Richard Vaglienti ¹, ¹West Virginia University, Morgantown, WV, ²Centers for Disease Control and Prevention, Division of Population Health, Atlanta, ³University at Buffalo - SUNY, Buffalo, NY, ⁴Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA
Background/Purpose: In 2016, 1 in 5 US adults reported chronic pain (CP). Osteoarthritis and rheumatoid arthritis are top causes of CP. The Stanford University Chronic…
Abstract Number: 275 • 2019 ACR/ARP Annual Meeting
Exercise Is Medicine® in Primary Care Practice: Provider Characteristics and Physical Activity Counseling for Patients with Arthritis, DocStyles, 2018
Dana Guglielmo¹, Louise Murphy ², Kristina Theis ¹, Charles Helmick ¹, John Omura ³ and Janet Croft ¹, ¹Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA, ²Centers for Disease Control and Prevention, Division of Population Health, Atlanta, ³Centers for Disease Control and Prevention, Division of Nutrition, Physical Activity, and Obesity, Atlanta, GA
Background/Purpose: Physical activity (PA) can reduce pain, prevent or delay disability, and improve physical functioning and mood in people with arthritis. However, only 36% of…
Abstract Number: 276 • 2019 ACR/ARP Annual Meeting
Effectiveness of Screening by Nurse with Predetermined Questionnaire on Infections Before Administration of Intravenous Biologics in Patients with Rheumatoid Arthritis
Sayaka Furukawa¹, Sho Fukui ¹, Sakura Tamaki ², Tomoko Nakasone ³ and Masato Okada ⁴, ¹St.Luke's International Hospital, Chuo-ku, Tokyo, Japan, ²St. Luke's International Hospital, Chuo-ku, Japan, ³St. Luke's International Hospital, Chuo-ku, Tokyo, Japan, ⁴St. Luke's International Hospital, Tokyo, Japan
Background/Purpose: Biologics are widely used as treatment for rheumatoid arthritis (RA), and pre-administration screening of active infection is imperative for the safety use. There is…
Abstract Number: 277 • 2019 ACR/ARP Annual Meeting
Efficacy of a Counselling Program to Promote Physical Activity in People with Inflammatory Arthritis
Linda Li¹, Hui Xie ², Na Lu ³, Chris Shaw ⁴, Diane Gromala ⁴, Catherine L. Backman ⁵, Johnathan Tam ⁶, Noonan Gregory ⁷, Alison Hoens ¹, Anne Townsend ⁸ and Lynne Feehan ¹, ¹University of British Columbia, Vancouver, BC, Canada, ²Arthritis Research Canada and Simon Fraser University, Vancouver, BC, Canada, ³Arthritis Research Canada, Vancouver, BC, Canada, ⁴Simon Fraser University, Surrey, BC, Canada, ⁵University of British Columbia, Vancouver, Canada, ⁶Arthritis Research Canada, Richmond, BC, Canada, ⁷Vancouver General Hospital, Vancouver, BC, Canada, ⁸Lancaster University, Lancaster, United Kingdom
Background/Purpose: Being physically active is key to successful management in people with inflammatory arthritis (IA). This study aimed to assess efficacy of a physical activity…
Abstract Number: 278 • 2019 ACR/ARP Annual Meeting
Improving a SLE-Quality Indicator Tool in an Outpatient Tertiary Care Setting
Jun Chu¹, Elaine Poncio ², Yenealem Temesgen-Oyelakin ², Michael Davis ³, Isabel Ochoa-Navas ², Sarthak Gupta ⁴, Zerai Manna ², Marquis Chapman ¹, Eileen Chu ⁵, Aidan Donnellan ⁶ and Sarfaraz Hasni ⁷, ¹National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, ²NIAMS/NIH, Bethesda, ³NIAMS/NIH, Bethesda, MD, ⁴Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, ⁵National Institutes of Health, Derwood, MD, ⁶National Institutes of Health, Bethesda, ⁷NIAMS, National Institutes of Health, Bethesda, MD
Background/Purpose: The care for patients with lupus is complex as they may exhibit multiple concomitant medical and socioeconomic issues. To address all their needs according…
Abstract Number: 279 • 2019 ACR/ARP Annual Meeting
Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases
Keith Colaco¹, Elsie Nguyen ², Shadi Akhtari ³, Paula Harvey ³ and Lihi Eder ⁴, ¹University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, ²University Health Network, Toronto, ON, Canada, ³Women's College Hospital, Toronto, ON, Canada, ⁴Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada
Background/Purpose: The value of non-invasive vascular imaging for cardiovascular (CV) risk stratification of patients with inflammatory rheumatic diseases is unclear. Measures of atherosclerosis including coronary…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].